ABBV vs MRK
Compare dividend stocks
AbbVie Inc. provides a 2.72% dividend yield, marginally above Merck & Company, Inc.'s 2.67%. Merck boasts a 14-year dividend streak and slightly better 3-year and 5-year CAGRs, though AbbVie leads in trailing twelve-month growth. In terms of safety and valuation, Merck is rated "watch" and "fair" by yield theory, unlike AbbVie which is "at_risk" and "overvalued."
Key differences
Yield
2.42%
MRK 2.33%
CAGR 5y
+6.8%
ABBV +6.8%
Safety
ABBV At risk
MRK At risk
Dividend score
ABBV 3/10
MRK 3/10
Price
Today
Dividend/share
Current yield A stock's annual dividend divided by today's share price — what a new buyer would earn right now. Learn more →
Growth (TTM)
CAGR 3y
5-year dividend CAGR The compound annual growth rate of a company's dividend over the last five full years — the steady yearly pace at which the payout has grown, smoothing out one-off jumps. Learn more →
Dividend growth streak The number of consecutive years a company has raised its dividend. A long streak signals reliability; 25+ years earns the "dividend aristocrat" label. Learn more →
Dividend status
Dividend doubling time Roughly how many years until the dividend doubles if it keeps growing at its recent rate, using the Rule of 72 (72 ÷ the growth rate as a percentage). A quick feel for how fast your income compounds — a 6% raiser doubles its payout in about 12 years. Learn more →
Dividend score
Safety
Quantic · Free
Unlock the full valuation comparison
Chowder number, fair value and Dividend Yield Theory for every stock — plus track them in your portfolio.
Need more? Pro adds portfolios, options income tracking & more AI. See Pro →